Instalab
logoInstalab

Giardia & Cryptosporidium Antigen Panel

Stool Test
Check for two common parasite infections when watery diarrhea keeps going.
4.9 (4,986 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped to you or available for pickup at nearby lab
Get results
Explained with clear next steps, no medical jargon

Should you take a Giardia & Cryptosporidium Antigen Panel test?

This test is most useful if any of these apply to you.

Still Having Diarrhea
Loose stools have lasted past two weeks, longer than a typical short stomach infection.
Back From Travel and Still Sick
Your diarrhea started during or after travel and hasn't cleared.
Worried About Water Exposure
You swallowed lake, pool, or well water, or you're around daycare spread.
Living With Weaker Immune Defenses
Your immune defenses are low, where Cryptosporidium can become severe or prolonged.

About Giardia & Cryptosporidium Antigen Panel

Persistent watery diarrhea is different from an ordinary stomach bug. Once it lasts past two weeks, parasites move up the list. Giardia and Cryptosporidium are two of the first to check, especially after lake water, untreated drinking water, travel, or daycare exposure.

These two infections can look alike from the outside. Both spread when contaminated stool reaches water, food, hands, or surfaces. The split matters because Giardia is usually treatable with prescription antiparasitic medicine, while Cryptosporidium often clears with fluids alone when immune defenses are healthy. A weakened immune system changes the stakes.

What This Panel Reveals

Each test looks for parasite proteins in stool. A Giardia antigen result and a Cryptosporidium antigen result ask a narrow question: was material from that organism found in this sample? They don't read DNA. They also aren't the same as a microscope exam, which looks for the parasite itself.

Testing for both is the point. The two infections share water and close-contact spread, and they can occur together. A DNA survey of Nigerian children found the two parasites together in a meaningful share of samples. That isn't a United States adult estimate. It shows the logic of paired testing: one negative result doesn't clear the other parasite.

The panel also separates two next steps. Giardia has several effective prescription options. Cryptosporidium often clears without treatment when immune defenses are healthy, but nitazoxanide can shorten illness for some. When immune defenses are weak, cryptosporidiosis can be prolonged or severe, and the benefit of nitazoxanide is less certain.

How to Read Your Results Together

Each result is positive or negative. The useful part is the pair.

PatternWhat It Suggests
Giardia positive, Cryptosporidium negativeGiardiasis is likely. This points to a treatable cause of greasy, gassy, bloated diarrhea.
Cryptosporidium positive, Giardia negativeCryptosporidiosis is likely. Fluids come first; weakened immune defenses make this more urgent.
Both positiveBoth infections may be present. Treat the Giardia side if symptoms fit, manage fluids, and check the shared exposure.
Both negativeThis does not rule out infection. A fresh sample or broader stool workup can still be useful if symptoms persist.

The result has the most weight when it fits the illness: watery diarrhea for Cryptosporidium, greasy or floating stools with gas and bloating for Giardia. Lab method matters too. If your report names a rapid Cryptosporidium card, interpret a faint positive more carefully. United States surveillance rules generally count that kind of unconfirmed result as probable rather than confirmed.

What to Do with Your Results

A positive Giardia result usually gives you a specific infection to treat. A positive Cryptosporidium result means fluids first; if your immune system is healthy, a prescription option may be reasonable. If your immune system is weakened, or diarrhea is severe or lasts beyond two weeks, bring in a clinician.

Both negative with symptoms that won't quit is a reason to repeat from another day or expand to a broader stool panel. Calprotectin can help show whether bowel inflammation is part of the picture. It doesn't identify the parasite.

Be careful with a quick test-of-cure. In Ethiopian children with cryptosporidiosis, stool shedding lasted a median of about a month after diarrhea began. A positive recheck soon after symptoms improve can mean the organism is still being shed, not that you need a new treatment right away. Recheck only if symptoms persist or public health rules require it.

When Results Can Be Misleading

Both parasites can be missed if the sample is taken on a day with little shedding. With profuse diarrhea a single sample is usually enough; samples from several days help most when suspicion stays high despite a first negative. A negative result also says nothing about bacteria, viruses, Cyclospora, Entamoeba, inflammatory bowel disease, or medication-related diarrhea. The panel answers two questions. It doesn't answer every diarrhea question.

Frequently Asked Questions

References

10 studies
  1. Andi L. Shane, Rajal K. Mody, John a. Crump, Phillip I. Tarr, Theodore S. Steiner, Karen Kotloff, Joanne M. Langley, Christine Wanke, Cirle Alcantara Warren, Allen C. Cheng, Joseph Cantey, Larry K. PickeringClinical Infectious Diseases2017
  2. Ibrahim a. Khalil, Christopher Troeger, Puja C. Rao, Brigette F. Blacker, Alexandria Brown, Thomas G. Brewer, Danny V. Colombara, Eugenio L. De Hostos, Cyril Engmann, Richard L. Guerrant, Rashidul Haque, Eric R. Houpt, Gagandeep Kang, Poonum S. Korpe, Karen L. Kotloff, Aldo a. M. Lima, William a. Petri Jr, James a. Platts-mills, David a. Shoultz, Mohammed H. Forouzanfar, Simon I. Hay, Robert C. Reiner Jr, Ali H. MokdadThe Lancet Global Health2018
  3. Beatrice Amadi, Mwiya Mwiya, John Musuku, Angela Watuka, Sandie Sianongo, Ayman Ayoub, Paul KellyLancet2002
  4. Mamun Kabir, Emtiaz Ahmed, Biplob Hossain, Masud Alam, Shahnawaz Ahmed, Mami Taniuchi, Carol a. Gilchrist, Eric R. Houpt, a. S. G. Faruque, William a. Petri Jr, Rashidul HaqueClinical Infectious Diseases2018